FATE Fate Therapeutics, Inc.

NASDAQ

$2.35

Fate Therapeutics, Inc. (FATE) Earnings News

Earnings press releases, previews and reviews for Fate Therapeutics, Inc. (FATE), newest first.

Thursday August 13, 2026 8:30 AM ET

Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

Wednesday May 13, 2026 8:30 AM ET

Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates